The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
October 29, 2012

Cancer research and education agreement announced between Baptist Memorial Health Care and Vanderbilt University

Exterior view of a multi-story hospital tower with white paneling, brick bands, rows of windows, and a glass-covered lower entrance.
October 18, 2012

Myelosuppression unit set to move to new CCT space

Seven researchers pose in a laboratory surrounded by benches, scientific equipment, glassware and supplies; one sits in front while the others stand behind.
October 4, 2012

Proteins help flip tumor’s invasive switch

Vanderbilt investigators have identified how two key components of cancer’s invasive “switch” — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.

Microscopic tissue section stained in pink and purple, showing densely packed abnormal-looking cells surrounding irregular white spaces with numerous red blood cells.
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

Illustration of the human respiratory system showing the lungs, bronchi, and rib cage in glowing purple, orange, and yellow tones.
September 21, 2012

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

A woman holds up a blue T-shirt as another woman in a red shirt hands it to her at a cancer-walk sign-up table decorated with balloons.
September 20, 2012

Photo: Signing up